JSL Industries (504080)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 17.60% indicates the operating business generates a meaningful return on capital employed.
• Latest quarter is profitable: ₹1 crore net profit on ₹14 crore sales, so the company is not losing money.
• Book value of ₹396.92 per share provides some asset backing, though the market price is far above it.
• The company still has a positive revenue base, with quarterly sales of ₹14 crore.

Concerns

• P/E of 65.38 is very high while profit fell 25.25% and sales fell 1.64%, leaving no margin of safety.
• ROE of only 4.23% is a poor return for equity shareholders.
• Piotroski F-Score of 3/9 and zero dividend yield suggest weak financial health and no compensation for waiting.
• Debt/Equity and promoter holding are not disclosed, creating uncertainty about financial risk and governance.

AI Analysis

When I look at JSL Industries, I start with earnings: what am I buying, and at what price? The market offers ₹234 crore market cap at ₹1,936.75 per share, but the trailing P/E is 65.38. That is a rich multiple for a company whose profit has fallen 25.25% and sales are down 1.64%. A wonderful business can sometimes deserve a high multiple, but this is not obviously wonderful: return on equity is only 4.23%, meaning shareholders' capital is earning very little. The 17.60% ROCE suggests operating units earn better, but with debt/equity not available, I cannot tell how much leverage or other claims stand between operating profit and equity holders. Graham taught me to buy with a margin of safety. At 4.88 times book value, there is no such margin. Book value per share is ₹396.92; the price is nearly five times that. The latest quarter shows ₹14 crore sales and only ₹1 crore net profit. That is a thin profit for a company valued at ₹234 crore. The Piotroski F-Score of 3 out of 9 reinforces the picture of weak financial health. And with zero dividend yield, I am not being paid to wait while the story unfolds. The stock sits at its 52-week high, having risen from ₹875, but price appreciation is not the same as business improvement. Mr. Market is enthusiastic; I need evidence in sales and earnings. This looks like a possible turnaround rather than a proven compounder. Only if future quarters show growth and higher ROE would the valuation begin to make sense. Until then, I would rather miss this rally than overpay for hope.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer